When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.

Cells in the back of the developing brain can give rise to brain tumors, suggesting they may be a target for treatment.

Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.

Some patients may need a combo of medications to combat a condition that causes dizziness.

Treatment with a drug used to prevent organ rejection partially reverses the course of tuberous sclerosis, research in mice suggests.

Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects.